Simponi and Orudis drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported only by a few people who take Simponi and Orudis together.
The phase IV clinical study analyzes what interactions people who take Simponi and Orudis have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2 people who take Simponi and Orudis together, and have interactions are studied.
What is Simponi?
Simponi has active ingredients of golimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 69,883 Simponi users for its effectiveness, alternative drugs and more.
What is Orudis?
Orudis has active ingredients of ketoprofen. eHealthMe is studying from 905 Orudis users for its effectiveness, alternative drugs and more.
Number of Simponi and Orudis reports submitted per year:
Common Simponi and Orudis drug interactions by gender *:
female:
- Chest discomfort
- Cognitive disorder
- Hypoacusis
- Visual acuity reduced
male:
n/a
Common Simponi and Orudis drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
- Cognitive disorder
- Hypoacusis
- Visual acuity reduced
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Chest discomfort
* Approximation only. Some reports may have incomplete information.
Do you take Simponi and Orudis?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Simponi and Orudis:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Simponi side effects:
- Drug ineffective: 23,312 reports
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 14,249 reports
- Pain: 12,493 reports
- Fatigue (feeling of tiredness): 9,973 reports
- Joint swelling: 8,956 reports
- Joint pain: 8,805 reports
- Rashes (redness): 8,590 reports
- Hair loss: 7,717 reports
Browse all side effects of Simponi:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Simponi interactions:
- Simponi and Methotrexate: 30,404 reports
- Simponi and Enbrel: 22,720 reports
- Simponi and Humira: 19,956 reports
- Simponi and Orencia: 18,966 reports
- Simponi and Prednisone: 16,696 reports
- Simponi and Actemra: 16,271 reports
- Simponi and Cimzia: 15,634 reports
- Simponi and Remicade: 15,488 reports
- Simponi and Arava: 15,170 reports
- Simponi and Sulfasalazine: 14,879 reports
Browse all interactions between Simponi and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Orudis interactions:
- Orudis and Methotrexate: 132 reports
Browse all interactions between Orudis and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on golimumab and ketoprofen (the active ingredients of Simponi and Orudis, respectively), and Simponi and Orudis (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Simponi and Orudis.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Imbruvica and Gastrointestinal Angiodysplasia Haemorrhagic - now
- Demerol and Sciatic Nerve Injury - 3 seconds ago
- Nph Insulin vs. Gabapentin - 3 seconds ago
- Sulfamethoxazole And Trimethoprim and Cellulitis Aggravated - 4 seconds ago
- Epinephrine and Sulfamethoxazole drug interaction - 7 seconds ago
- Prohance and Eye Irritation - 8 seconds ago
- Zubsolv and Weight Increased - 12 seconds ago
- Methylfolate and Estring drug interaction - 14 seconds ago
- Sulfasalazine and Pneumoperitoneum - 15 seconds ago
- Singulair and Bacteriuria - 15 seconds ago